APM
BCAB icon

Avidity Partners Management’s BioAtla BCAB Stock Holding History

Avidity Partners Management’s Portfolio BCAB Stock Details BCAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-12,050
Closed -$1.61M – 98
2023
Q1 		$1.61M Sell
12,050
-13,150
-52% -$2.37M 0.05% 80
2022
Q4 		$10.4M Buy
+25,200
New +$10.5M 0.23% 59
2021
Q1 		– Sell
-1,000
Closed -$1.7M – 99
2020
Q4 		$1.7M Buy
+1,000
New +$1.67M 0.06% 92

Other funds holding BCAB

SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Avidity Partners Management's BCAB Position: Q2 2023 in Review

Avidity Partners Management sold out of BioAtla (BCAB) in Q2 2023, closing a stake of 12,050 shares — an estimated $1.61M sold.

Avidity Partners Management first reported a position in BCAB in Q4 2020 and held it in 3 quarters. The position peaked at $10.4M in Q4 2022. 87 funds tracked by Wall St. Rank hold BCAB as of Q2 2023.

  • Avidity Partners Management reported no remaining BioAtla position as of Q2 2023 after selling out during the quarter.
  • Avidity Partners Management sold 12,050 BioAtla shares in Q2 2023, an estimated $1.61M.
  • Avidity Partners Management first reported a position in BioAtla in Q4 2020 and held it in 3 quarters.
  • Avidity Partners Management's BioAtla position peaked at $10.4M in Q4 2022.
  • 87 funds tracked by Wall St. Rank held BioAtla as of Q2 2023.

Based on Avidity Partners Management's 13F filing for Q2 2023, filed 14 Aug 2023.